{"id":673542,"date":"2023-10-24T00:24:01","date_gmt":"2023-10-24T00:24:01","guid":{"rendered":"https:\/\/www.abnewswire.com\/pressreleases\/?p=673542"},"modified":"2023-10-24T00:24:01","modified_gmt":"2023-10-24T00:24:01","slug":"urbn-dental-introduces-fdacleared-vivos-mmrna-obstructive-sleep-apnea-and-snoring-treatment","status":"publish","type":"post","link":"https:\/\/www.abnewswire.com\/pressreleases\/urbn-dental-introduces-fdacleared-vivos-mmrna-obstructive-sleep-apnea-and-snoring-treatment_673542.html","title":{"rendered":"URBN Dental Introduces FDA-Cleared Vivos mmRNA Obstructive Sleep Apnea and Snoring Treatment"},"content":{"rendered":"
The Vivos mmRNA Sleep Apnea treatment is a practical alternative to CPAP.<\/div>\n

\"\"<\/p>\n

URBN Dental<\/a>, a leading name in Dental healthcare, has taken a significant stride in the realm of sleep apnea treatment. The esteemed dental practice is now offering the FDA-cleared Vivos mmRNA Sleep Apnea treatment<\/a> as an effective alternative to CPAP (Continuous Positive Airway Pressure) therapy. It is a non-surgical solution that expands the palate and makes space for the tongue to eliminate snoring as well as open up the airway to treat Obstructive Sleep Apnea.<\/p>\n

Sleep apnea, a prevalent sleep disorder affecting millions worldwide, often leads to disrupted sleep, snoring, and various health-related issues. URBN Dental’s introduction of the FDA cleared and approved Vivos mmRNA treatment marks a notable advancement in the field of sleep medicine, providing a more comfortable and practical solution for those suffering from sleep apnea.<\/p>\n

Traditional sleep apnea treatments typically involve CPAP machines, surgical implants, or overnight stays in laboratories for sleep studies. URBN Dental’s innovative approach aims to make the path to better sleep smoother and more convenient. The first step of the treatment includes take-home sleep tests that involve wearing a specialized ring at night for several days to gather essential data.  After data is collected a specialized mmRNA Vivos Appliance is custom made for the patient to expand the patient’s palate and grow bone over a duration of typically 12 months.  This expansion of palate allows for space for the tongue, opens the airway, and also fixes facial symmetry in most patients.  It is truly a nonsurgical treatment with permanent results.<\/p>\n

The results of this groundbreaking treatment are nothing short of remarkable. Within a year of commencing the Vivos mmRNA therapy, most patients report a significant reduction if not elimination in snoring and, more importantly, a substantial improvement in their sleep apnea symptoms from the opened airway. The treatment method excels not only in addressing sleep disorders but also in enhancing overall oral health.<\/p>\n

 \"\"<\/p>\n

Key benefits of the Vivos mmRNA Sleep Apnea treatment include:<\/strong><\/p>\n

1. Space for the Tongue:<\/strong> The Vivos device creates space for the tongue, allowing for better airflow and reducing instances of sleep-disordered breathing.<\/p>\n

2. Palate Expansion:<\/strong> Patients experience an expansion of the palate, resulting in better airflow and breathing during sleep.<\/p>\n

3. Teeth Straightening:<\/strong> The Vivos treatment can effectively improve teeth alignment, leading to a more attractive and functional smile.<\/p>\n

4. Facial Symmetry:<\/strong> The expansion of the palate and facial bone growth enhances oral health and improves facial symmetry, creating a more aesthetically pleasing appearance.<\/p>\n

URBN Dental’s commitment to providing patients with a long-term solution for better sleep is evident in its adoption of the Vivos Method. By saying goodbye to restless nights due to snoring and sleep-disordered breathing, patients can reclaim their quality of life and enjoy the rejuvenating effects of a good night’s sleep.<\/p>\n

Dr. David Nguyen, the founder of URBN Dental, commented on the introduction of the Vivos mmRNA treatment, saying, “We are excited to offer our patients a highly effective and convenient alternative to traditional sleep apnea treatments. The Vivos Method not only helps alleviate sleep apnea symptoms but also promotes overall oral health. We believe this is a game-changer for individuals looking to improve their sleep quality and overall well-being.”<\/p>\n

URBN Dental invites individuals struggling with sleep apnea and related issues to inquire about the Vivos Method and take the first step toward better sleep and healthier life.<\/p>\n

For any media or commercial inquiries, users can visit the official website www.urbndental.com<\/a>.<\/p>\n

To learn more about  Vivos mmRNA Sleep Apnea treatment, visit: https:\/\/sleepapneatreatment.com<\/a><\/p>\n

Media Contact<\/span>
Company Name:<\/strong> URBN Dental<\/a>
Contact Person:<\/strong> David Nguyen
Email:<\/strong> Send Email<\/a>
City:<\/strong> Houston
State:<\/strong> TX
Country:<\/strong> United States
Website:<\/strong> www.urbndental.com<\/a><\/p>\n

<\/object>\"\"<\/p>\n","protected":false},"excerpt":{"rendered":"

The Vivos mmRNA Sleep Apnea treatment is a practical alternative to CPAP. URBN Dental, a leading name in Dental healthcare, has taken a significant stride in the realm of sleep apnea treatment. The esteemed dental practice is now offering the … Continue reading →<\/span><\/a><\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[401,426,411,404],"tags":[],"class_list":["post-673542","post","type-post","status-publish","format-standard","hentry","category-Business","category-Financial-Market","category-Technology","category-US"],"_links":{"self":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/673542","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/comments?post=673542"}],"version-history":[{"count":0,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/posts\/673542\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/media?parent=673542"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/categories?post=673542"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.abnewswire.com\/pressreleases\/wp-json\/wp\/v2\/tags?post=673542"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}